~~<i id='C65D2CCDA4'><strike id='C65D2CCDA4'><tt id='C65D2CCDA4'><pre id='C65D2CCDA4'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

knowledge

author：entertainment 2025-09-28 23:48:27 - browse：86

Eli Lilly said Friday that it will acquire Dermira, a small biotech developing drugs for chronic skin conditions, for $1.1 billion.

The centerpiece of the deal is the Dermira drug called lebrikizumab that aims to treat people suffering from moderate-to-severe atopic dermatitis, the most common form of eczema, a disease characterized by inflamed, itchy, and scaly skin.

Phase 3 clinical trials of lebrikizumab in atopic dermatitis are underway. If successful, the drug could compete against Dupixent, which has grown into a commercial blockbuster for Regeneron Pharmaceuticals and Sanofi.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Poland's lawmakers approve a divisive law on Russian influence

hotspot

leisure time

hotspot

leisure time

hotspot

AdobeTheartificialwomb,adeviceaimingtosaveinfantsbornwaytoosoon,isinchingclosertobeingtestedinhumans

WSS

House GOP plan to stem drug shortages differs from Democrats’

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Midwives could help bridge maternal health disparities in the U.S.

What AstraZeneca

Neurocrine congenital adrenal hyperplasia trial succeeds

People with substance use disorder deserve online privacy

focus

knowledge

hotspot

Walensky prepares to leave CDC — and Congress — behind

Many immigrants are left out of maternal health programs

BioMarin wins approval for gene therapy to treat hemophilia A

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Dobbs anniversary: the lost opportunity of abortion as health care

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

Virginia high school admissions case could be legal follow

Why the quest to eradicate polio has stumbled

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Typhoon Doksuri makes landfall in China after bringing deadly landslides to Philippines

hotspot

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

Chamber of Commerce, DOJ clash in court over drug prices

Snowpack in the West is melting rapidly. Where will all that extra water go?

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

leisure time

hotspot

leisure time

hotspot